Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Siemens Healthcare Team on PCR-Based Molecular Dx Workflow

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Siemens Healthcare have announced a new strategic relationship to integrate Thermo Fisher's real-time PCR into Siemens' Versant kPCR molecular diagnostics platform.

The partners have already combined the technologies into a workflow that Siemens will display next week at the European Congress of Clinical Microbiology and Infectious Disease.

"We are excited to collaborate with Siemens in support of its Versant kPCR Molecular Solution as we work to expand our partnerships in the diagnostics space," Drew Burch, Thermo Fisher's head of licensing and commercial supply, said in a statement.

Thermo Fisher offers a real-time PCR ecosystem of reagents, instruments, and assays.

Siemens' Versant kPCR Molecular System has proved to be a platform upon which emerging infectious disease assays can be run. Last month, Siemens released a research-use-only Zika virus test, and in recent years other diagnostics firms have developed qPCR assays, such as a MERS test, that can run on Versant.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.